Staar Surgical Company Receives a Buy from Canaccord Genuity

In a report released today, Jason Mills from Canaccord Genuity reiterated a Buy rating on Staar Surgical Company (NASDAQ: STAA), with a price target of $21. The company’s shares opened today at More »

Analysts Have Conflicting Sentiments on These Healthcare Companies: Amgen Inc (NASDAQ: AMGN), Tesaro (NASDAQ: TSRO) and Spero Therapeutics Inc (NASDAQ: SPRO)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amgen Inc (NASDAQ: AMGN), Tesaro (NASDAQ: TSRO) and Spero Therapeutics Inc (NASDAQ: SPRO). TipRanks has tracked 36,000 More »